Travere Therapeutics
TVTX
TVTX
235 hedge funds and large institutions have $2.41B invested in Travere Therapeutics in 2025 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 72 increasing their positions, 78 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.21% less ownership
Funds ownership: 113.21% → 113% (-0.21%)
8% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 78
Holders
235
Holding in Top 10
3
Calls
$77.4M
Puts
$25.5M
Top Buyers
| 1 | +$70.8M | |
| 2 | +$43.7M | |
| 3 | +$38.2M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$25.9M |
Top Sellers
| 1 | -$51.4M | |
| 2 | -$24.1M | |
| 3 | -$17.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15.6M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$14.6M |
